Lawrence W. Hartley
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, Carbohydrate Chemistry and Synthesis, Adenosine and Purinergic Signaling, Peptidase Inhibition and Analysis, T-cell and B-cell Immunology
Most-Cited Works
- → Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2(1995)214 cited
- → Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 3. Indole-3-glyoxamides(1996)91 cited
- → Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI(1999)88 cited
- → Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 1. Indole-3-acetamides(1996)70 cited
- → Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 2. Indole-3-acetamides with Additional Functionality(1996)48 cited
- → Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors(1996)35 cited
- → Dissociation of the effects of p-chlorophenylalanine on self-stimulation and on brain serotonin(1970)25 cited
- → The immunomodulatory action of frentizole, a novel immunosuppressive agent(1982)18 cited
- → Carbocyclic[g]indole Inhibitors of Human Nonpancreatic s-PLA2(2005)17 cited
- → ChemInform Abstract: Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. Part 3. Indole‐3‐glyoxamides.(1997)5 cited